Original language | English (US) |
---|---|
Pages (from-to) | 2237-2241 |
Number of pages | 5 |
Journal | Journal of the American Society of Nephrology |
Volume | 31 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2020 |
All Science Journal Classification (ASJC) codes
- General Medicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American Society of Nephrology, Vol. 31, No. 10, 10.2020, p. 2237-2241.
Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Improving care for patients after hospitalization with AKI
AU - Siew, Edward D.
AU - Liu, Kathleen D.
AU - Bonn, John
AU - Chinchilli, Vernon
AU - Dember, Laura M.
AU - Girard, Timothy D.
AU - Greene, Tom
AU - Hernandez, Adrian F.
AU - Alp Ikizler, T.
AU - James, Matthew T.
AU - Kampschroer, Kevin
AU - Kopp, Jeffrey B.
AU - Levy, Marla
AU - Palevsky, Paul M.
AU - Pannu, Neesh
AU - Parikh, Chirag R.
AU - Rocco, Michael V.
AU - Silver, Samuel A.
AU - Thiessen-Philbrook, Heather
AU - Wald, Ron
AU - Xie, Yining
AU - Kimmel, Paul L.
AU - Star, Robert A.
N1 - Funding Information: E. Siew is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant U01DK082192 and U.S. Department of Veterans Affairs grant IIR 13-073. K. Liu is supported by National Institutes of Health (NIH) grant R01DK122797. C. Parikh is supported by NIH grant R01-HL-085757, O’Brien Kidney Center grant P30-DK-079310, and is a member of the NIH-sponsored Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Consortium (grant U01-DK-082185). Funding Information: Dr. Laura M. Dember reports receiving grants from NIDDK; consulting fees from Merck; and personal fees from GlaxoSmithKline, outside the submitted work. Dr. Timothy D. Girard reports grants from National Institutes of Health (NIH), outside the submitted work. Dr. Adrian F. Hernandez reports grants and personal fees from AstraZeneca; personal fees from Amgen; personal fees from Bayer; grants and personal fees from Merck; grants and personal fees from Boehringer Ingelheim; and grants and personal fees from Novartis, outside the submitted work. Dr. T. Alp Ikizler reports personal fees from Abbott Renal Care, Fresenius Kabi, and the International Society of Nephrology, outside the submitted work. Dr. Matthew T. James reports research support from the Canadian Institutes of Health Research New Investigator Award, outside of the submitted work. Dr. Neesh Pannu reports receiving research support from the Canadian Institutes of Health Research and Alberta Health Services, outside the submitted work. Dr. Kathleen D. Liu reports personal fees from American Thoracic Society, AstraZeneca, Baxter, Bi-omerieux,Durect, PotreroMed,Quark,and Theravance; and other from Amgen, the National Policy Forum on Critical Care and ARF, and UpToDate, outside the submitted work. Dr. Paul M. Palevsky reports personal fees from Baxter and grants from Dascena and BioPorto, outside the submitted work. Dr. Chirag R. Parikh reports other from Akebia Therapeutics and Renalytix AI, outside of the submitted work. Dr. Edward D. Siew reports consulting fees for Akebia, Inc. in 2019; honorarium as an invited speaker at the Da Vita Annual Physician Leadership Conference in 2019; royalties as an author for UpToDate; and compensation for serving on the editorial board for the Clinical Journal of the American Society of Nephrology, outside the submitted work. Dr. Samuel A. Silver reports speaking fees from Baxter Canada, outside the submitted work. Funding Information: E. Siew is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant U01DK082192 and U.S. Department of Veterans Affairs grant IIR 13-073. K. Liu is supported by National Institutes of Health (NIH) grant R01DK122797. C. Parikh is supported by NIH grant R01-HL-085757, O'Brien Kidney Center grant P30-DK-079310, and is a member of the NIH-sponsored Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Consortium (grant U01-DK-082185).
PY - 2020/10
Y1 - 2020/10
UR - http://www.scopus.com/inward/record.url?scp=85092246652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092246652&partnerID=8YFLogxK
U2 - 10.1681/ASN.2020040397
DO - 10.1681/ASN.2020040397
M3 - Review article
C2 - 32912935
AN - SCOPUS:85092246652
SN - 1046-6673
VL - 31
SP - 2237
EP - 2241
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 10
ER -